E Fund Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Sell |
13,246
-1,810
| -12% | -$158K | 0.06% | 149 |
|
|
2025
Q1 | $1.03M | Buy |
15,056
+5,231
| +53% | +$357K | 0.05% | 165 |
|
|
2024
Q4 | $764K | Buy |
9,825
+2,899
| +42% | +$225K | 0.04% | 176 |
|
|
2024
Q3 | $464K | Buy |
6,926
+1,471
| +27% | +$98.6K | 0.02% | 203 |
|
|
2024
Q2 | $618K | Buy |
5,455
+331
| +6% | +$37.5K | 0.03% | 159 |
|
|
2024
Q1 | $711K | Buy |
5,124
+31
| +0.6% | +$4.3K | 0.04% | 134 |
|
|
2023
Q4 | $632K | Sell |
5,093
-22
| -0.4% | -$2.73K | 0.04% | 121 |
|
|
2023
Q3 | $477K | Buy |
5,115
+819
| +19% | +$76.4K | 0.04% | 127 |
|
|
2023
Q2 | $552K | Sell |
4,296
-760
| -15% | -$97.7K | 0.04% | 106 |
|
|
2023
Q1 | $587K | Sell |
5,056
-282
| -5% | -$32.7K | 0.04% | 110 |
|
|
2022
Q4 | $604K | Sell |
5,338
-818
| -13% | -$92.6K | 0.05% | 115 |
|
|
2022
Q3 | $496K | Buy |
6,156
+284
| +5% | +$22.9K | 0.05% | 126 |
|
|
2022
Q2 | $438K | Buy |
5,872
+360
| +7% | +$26.9K | 0.04% | 171 |
|
|
2022
Q1 | $705K | Buy |
5,512
+144
| +3% | +$18.4K | 0.02% | 103 |
|
|
2021
Q4 | $721K | Buy |
5,368
+40
| +0.8% | +$5.37K | 0.03% | 126 |
|
|
2021
Q3 | $728K | Buy |
+5,328
| New | +$728K | 0.03% | 110 |
|
|
2021
Q1 | $495K | Buy |
+5,512
| New | +$495K | 0.04% | 136 |
|